| Literature DB >> 28594922 |
Chin-Sheng Hung1,2, Sheng-Wei Chang1, Li-Min Liao1, Cheng-Chiao Huang1, Shih-Hsin Tu1,2, Shou-Tung Chen3,4,5, Dar-Ren Chen3,4,5, Shou-Jen Kuo4,5, Hung-Wen Lai3,4,5,6, Ting-Mao Chou7, Yao-Lung Kuo8,9.
Abstract
INTRODUCTION: Laparoscopic techniques are commonly used in abdominal and gynecologic surgery, while breast cancer surgery has remained largely unchanged. In Asia, especially in Japan, many surgeons have started to use endoscopic surgery for breast cancer. In Taiwan, endoscopy-assisted breast surgery started in 2010. The benefits of this surgical method include smaller incisions, an axillary anatomic approach, clear vision, no oncologic compromise, and good cosmetic outcomes. This is the first report to discuss the learning curve of endoscopy-assisted breast surgery, including the difficulties experienced.Entities:
Mesh:
Year: 2017 PMID: 28594922 PMCID: PMC5464537 DOI: 10.1371/journal.pone.0178251
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Endoscopic mastectomy.
(a) periareolar and axillary incision; (b) the dissected breast tissue; (c) immediate reconstruction with jelly implant (right side is another biopsy for benign fibroadenoma). It has the benefits of smaller incisions, no oncologic compromise, and good cosmetic outcomes.
Fig 2The learning curve of endoscopic total mastectomy.
Both hospitals (a) TMUH and (b) CCH have the similar learning curve.
Fig 3The learning curve of endoscopic partial mastectomy in TMUH.
Fig 4Learning group and mature group.
Total 203 patients received an endoscopic mastectomy and 134 unilateral total mastectomy patients were divided into learning group and mature group.
Clinicopathologic factors according to operative experience.
| Learning phase (n = 30) | Mature phase (n = 104) | P | |
|---|---|---|---|
| Age | 51.43 ± 7.98 | 49.81 ± 10.70 | 0.442 |
| Height | 156.26 ± 4.41 | 157.40 ± 6.04 | 0.343 |
| Weight | 55.99 ± 7.28 | 58.11 ± 9.88 | 0.282 |
| BMI | 22.88 ± 2.43 | 23.45 ± 3.69 | 0.435 |
| Tis | 6 (20%) | 20 (19.2%) | 0.35 |
| T1 | 8 (26.7%) | 42 (40.4%) | |
| T2 | 12 (40%) | 34 (32.7%) | |
| T3 | 4 (13.3%) | 6 (5.8%) | |
| N0 | 23 (76.7%) | 77 (74.0%) | 0.582 |
| N1 | 4 (13.3%) | 21 (20.2%) | |
| N2 | 3 (10.0%) | 5 (4.8%) | |
| N3 | 0 | 1 (1.0%) | |
| 0 | 6 (20.0%) | 21 (20.2%) | 0.087 |
| I | 6 (20.0%) | 37 (35.6%) | |
| IIA | 11 (36.7%) | 23 (22.1%) | |
| IIB | 3 (10.0%) | 18 (17.3%) | |
| IIIA | 4 (13.3%) | 3 (2.9%) | |
| IIIB | 0 | 0 | |
| IIIC | 0 | 1 (1.0%) | |
| Nipple sparing | 18 (60.0%) | 69 (66.3%) | 0.521 |
| Skin sparing (nipple not preserved) | 12 (40.0%) | 35 (33.7%) | |
| Right | 15 (50.0%) | 42 (40.4%) | 0.348 |
| Left | 15 (50.0%) | 62 (59.6%) | |
| Ductal carcinoma in situ | 6 (20.0%) | 21 (20.2%) | 0.268 |
| Invasive ductal carcinoma | 16 (53.3%) | 62 (59.6%) | |
| others | 8 (26.7%) | 21 (20.2%) | |
| No | 27 (90.0%) | 98 (94.2%) | 0.423 |
| Yes | 3 (10.0%) | 6 (5.8%) | |
| Negative | 7 (23.3%) | 21 (20.2%) | 0.728 |
| Positive | 23 (76.7%) | 82 (78.9%) | |
| Negative | 13 (43.3%) | 39 (37.5%) | 0.589 |
| Positive | 17 (56.7%) | 64 (61.5%) | |
| -ive | 23 (76.7%) | 83 (79.8%) | 0.639 |
| +ive | 7 (23.3%) | 20 (19.2%) |
The relationship between clinical factors and the operative experience.
| Learning phase (n = 30) | Mature phase (n = 104) | p | |
|---|---|---|---|
| 330 ± 141.69 | 337 ± 148.87 | 0.853 | |
| 275.33 ± 46.35 | 228.91 ± 54.32 | 0.000 | |
| No | 28 (93.3%) | 103 (99.0%) | 0.094 |
| Yes | 2 (6.7%) | 1 (1.0%) | |
| Sentinel | 21 (70.0%) | 74 (71.2%) | 0.697 |
| Sentinel then dissection | 6 (20.0%) | 24 (23.1%) | |
| dissection | 3 (10.0%) | 6 (5.7%) | |
| No | 13 (43.3%) | 40 (38.5%) | 0.889 |
| Gel implant | 14 (46.7%) | 47 (45.2%) | |
| TRAM | 1 (3.3%) | 8 (7.7%) | |
| Others | 2 (6.7%) | 9 (8.6%) | |
| No | 16 (53.3%) | 83 (79.8%) | 0.007 |
| Yes | 11 (36.7%) | 16 (15.4%) | |
| Not record | 3 (10.0%) | 5 (4.8%) |
*p < 0.05 means statistically significant